![NXERA CONTEMPLATIVE TRAILS BLUE 1 8 K](/_next/image?url=https%3A%2F%2Fsosei-heptares.ams3.cdn.digitaloceanspaces.com%2FBrand-Images%2FContemplative%2F_2000xAUTO_crop_center-center_none%2FNXERA-CONTEMPLATIVE-TRAILS_BLUE_1_8K.jpg&w=3840&q=75)
Clinical Data & Presentations
Information on clinical trials that we are conducting or have conducted is available here, but it is not to promote or advertise our products nor the efficacy/effectiveness of our products. The results of the clinical studies are the findings at the time of completion of the studies and do not represent the latest information. Please refer to the package insert for further information on the approved indications of the drug. Please view this site only if you agree to the above.
Clinical Data & Presentations
Filter
Search
1st April 2022
Effects of clazosentan on cerebral vasospasm-related morbidity and all-cause mortality after aneurysmal subarachnoid hemorrhage: two randomized phase 3 trials in Japanese patients Journal of Neurosurgery
1st February 2022
Safety and efficacy of daridorexant in patients with insomnia disorder: results from two multicentre, randomised, double-blind, placebo-controlled, phase 3 trials The Lancet Neurology